The Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc. (GCAN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GCAN · as of Jun 9, 2026
Key Statistics
Explore The Greater Cannabis Company, Inc. Data
gcan stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gcan competitorsGCAN
ADVT
BBBT
CANL
EAPH
GREHStock Performance
Full HistoryAbout The Greater Cannabis Company, Inc.
The Greater Cannabis Company, Inc. is dedicated to developing and bringing to market medical treatments that utilize cannabinoids. They feature an innovative oral patch delivery system, designed to ef…
what is the greater cannabis company, inc. · gcan stock overview · the greater cannabis company, inc. company profile · who is the greater cannabis company, inc. ceo · gcan OTC · the greater cannabis company, inc. headquarters · the greater cannabis company, inc. business segments
About Stock Overview & Key Data
The Greater Cannabis Company, Inc. (GCAN) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Sep 18, 2018. As of the latest trading session, GCAN stock price is $0.30, with a market capitalization of $283,008. The stock has returned +119700.00% over the past 12 months and +299.33% year-to-date.
In fiscal year 2025, The Greater Cannabis Company, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, The Greater Cannabis Company, Inc. (GCAN) stock price is $0.30. The stock is traded on OTC under the ticker symbol GCAN. The 52-week range is $0.04 – $0.60.